Episodes: 15
Frequency: Irregular
Rating: 5.0/5.0
Estimated listeners: 100 - 1,000
Gender skew: Male
Listener location: USA
Publicly listed emails
info@practicalneurology.com
analytics@bmctoday.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Elyse Perweiler, RN, MPP - Standardized Workflows And Digital Cognitive Screening For Early Alzheimer Detection
Tim MacLeod, PhD - Operationalizing Early Cognitive Screening In Health Systems; Scalable Workflows And Digital Tools For Alzheimer Care Access
Dr. Pascal Sati - Prls And Susceptibility-based MRI For Differentiating MS From Mimics; Evolving Mcdonald Criteria
Dr. Daniel Ontaneda - Paramagnetic Rim Lesions (prls) And Updates To Diagnostic Criteria For Multiple Sclerosis
Patrick Y. Wen, MD - Molecular Markers, WHO Classification, And Targeted Therapies For Low- And High-grade Gliomas
Tavapadon Treatment for Early Parkinson Disease: Findings from the TEMPO Trials
September 25, 2026
Hubert Fernandez, MD, Cleveland Clinic, Cleveland, OH, discusses findings from the TEMPO trials evaluating tavapadon, a selective dopamine D1/D5 receptor partial agonist, as monotherapy in early Parkinson disease and as an adjunct to levodopa in patients with motor fluctuations. He examines efficacy, tolerability, adverse events, and where tavapadon could fit within the evolving Parkinson disease treatment landscape.
Could a Novel Oral Therapy Change How Clinicians Treat Obstructive Sleep Apnea? Insights From the SynAIRgy Trial
September 03, 2026
In this episode, Patrick J. Strollo Jr, MD, FACP, FCCP, FAASM, of the University of Pittsburgh Department of Medicine, Pittsburgh, PA, discusses the data from the phase 3 SynAIRgy clinical trial for AD109, an investigational once-nightly oral treatment targeting neuromuscular dysfunction in obstructive sleep apnea, and its potential role in a more personalized approach to OSA care.
Part II: Early Alzheimer Disease Detection through a Davos Alzheimer's Collaborative Initiative: Lessons from Real-World Implementation
June 12, 2026
This episode explores the real-world implementation of the Davos Alzheimer’s Collaborative Healthcare System Preparedness (DAC-SP) US Early Detection Program at Virtua Health, examining outcomes in identifying cognitive impairment, streamlining referrals, and supporting efficient use of clinical resources. Elyse Perweiler, RN, MPP, Professor, Rowan–Virtua School of Osteopathic Medicine, Stratford, NJ, and Tim MacLeod, PhD, Executive Director, Healthcare System Preparedness Program, DAC, Toron...
Brain Matters (Audio) · High booking difficulty · 100 - 1,000 listeners
Its publicly listed emails are info@practicalneurology.com and analytics@bmctoday.com. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed emails for Neurology: Disease Deep Dive: info@practicalneurology.com and analytics@bmctoday.com.
Podseeker estimates Neurology: Disease Deep Dive reaches 100 to 1,000 listeners per episode. Only the publisher has exact numbers.
Neurology: Disease Deep Dive typically books industry leaders. Typical guest background: MD/PhD/academic clinician-researchers with leadership roles at major academic medical centers and large neuroscience programs. Common among recent guests: Academic faculty appointments; Leadership in multisite clinical research/consortia; Contributions to diagnostic criteria or disease classification. Recent guests include Elyse Perweiler, RN, MPP, Tim MacLeod, PhD, and Dr. Pascal Sati.
High. It mostly books established leaders in its field.
Recent episodes cover Neurology, Alzheimer, Multiple Sclerosis, Glioma, and Dementia. Pitch an idea tied to one of these topics and mention a recent episode.
Publicly listed emails
info@practicalneurology.com
analytics@bmctoday.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings